- Home
- OGE vs ARWR Comparison
OGE vs ARWR Comparison
Compare OGE & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGE | ARWR |
|---|---|---|
| Founded | 1902 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.2B |
| IPO Year | 2009 | 2009 |
Fundamental Metrics
Financial Performance| Metric | OGE | ARWR |
|---|---|---|
| Price | $49.94 | $85.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $48.78 | ★ $83.40 |
| AVG Volume (30 Days) | 1.3M | ★ 2.4M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | 5.94 | ★ 99.80 |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $3,260,100,000.00 | $16,142,321.00 |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $1.42 | N/A |
| P/E Ratio | $206.71 | ★ N/A |
| Revenue Growth | ★ 9.21 | N/A |
| 52 Week Low | $41.70 | $15.01 |
| 52 Week High | $50.26 | $95.49 |
Technical Indicators
Market Signals| Indicator | OGE | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 59.54 | 59.26 |
| Support Level | $46.21 | $70.03 |
| Resistance Level | $50.13 | $86.19 |
| Average True Range (ATR) | 0.83 | 4.14 |
| MACD | 0.05 | 0.84 |
| Stochastic Oscillator | 84.52 | 60.82 |
Price Performance
Historical ComparisonAbout OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.